The FDA label for<unk>  carries a boxed warning for cytokine release syndrome (CRS), neurologic toxicity, hemophagocytic lymphohistiocytosis/macrophage activation syndrome (HLH/MAS), and prolonged cytopenia. CRS and HLH/MAS are systemic responses to the activation and proliferation of CAR-T cells causing high fever and flu-like symptoms, and prolonged cytopenia is a drop in the number of a certain blood cell type for an extended period of time.
Idecabtagene vicleucel
Ciltacabtagene autoleucel
Lisocabtagene maraleucel
Brexucabtagene autoleucel
Ibrexafungerp
Titermax
Sabizabulin
Clinatec